| Literature DB >> 2459765 |
D Bttig1.
Abstract
After reviewing the different pharmacological treatments of psychotic states, the author presents an evaluation of the clinical effectiveness of Clopixol Acutard (zuclopenthixol acetate in a viscoleo solution): 48% of the 23 patients (14 acute psychoses and 9 acute phases in chronic psychotic patients) respond well to the treatment, and only 17% suffered from important side effects, which demonstrates the good tolerance of the medication. Clopixol Acutard convinces by its rapid effect and with a mean of 5 injections leads to sedation, which is particularly helpful in patients with paranoid symptoms. The treatment interval, i.e. an injection every 2 or 3 days, is appreciated by the patients as well as by the therapists, for it establishes a less intrusive relationship.Entities:
Mesh:
Substances:
Year: 1988 PMID: 2459765
Source DB: PubMed Journal: Schweiz Arch Neurol Psychiatr (1985) ISSN: 0258-7661